Vanguard Group Inc G1 Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.12 Trillion
Q2 2024

A detailed history of Vanguard Group Inc transactions in G1 Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,491,109 shares of GTHX stock, worth $17.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,491,109

Previous 2,081,573 19.67%

Holding current value

$17.8 Million

Previous $8.99 Million 36.84%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.2 - $4.98 $900,979 - $2.04 Million	409,536 Added 19.67%	2,491,109 $5.68 Million
Q1 2024 May 10, 2024	BUY	$2.1 - $4.83 $209,790 - $482,517	99,900 Added 5.04%	2,081,573 $8.99 Million
Q4 2023 Feb 14, 2024	BUY	$1.12 - $3.73 $35,397 - $117,886	31,605 Added 1.62%	1,981,673 $6.04 Million
Q2 2023 Aug 14, 2023	SELL	$2.46 - $3.14 $100,139 - $127,819	-40,707 Reduced 2.04%	1,950,068 $4.86 Million
Q1 2023 May 15, 2023	BUY	$2.57 - $8.16 $166,870 - $529,828	64,930 Added 3.37%	1,990,775 $5.34 Million
Q4 2022 Feb 10, 2023	BUY	$5.19 - $13.5 $1.24 Million - $3.23 Million	239,392 Added 14.19%	1,925,845 $10.5 Million
Q3 2022 Nov 14, 2022	BUY	$5.17 - $16.99 $340,971 - $1.12 Million	65,952 Added 4.07%	1,686,453 $21.1 Million
Q2 2022 Aug 12, 2022	SELL	$4.04 - $8.51 $1.22 Million - $2.58 Million	-303,203 Reduced 15.76%	1,620,501 $8.01 Million
Q1 2022 May 13, 2022	SELL	$7.6 - $11.02 $4.72 Million - $6.84 Million	-620,661 Reduced 24.39%	1,923,704 $14.6 Million
Q4 2021 Feb 14, 2022	BUY	$10.16 - $16.17 $389,097 - $619,262	38,297 Added 1.53%	2,544,365 $26 Million
Q3 2021 Nov 12, 2021	BUY	$13.16 - $22.47 $42,664 - $72,847	3,242 Added 0.13%	2,506,068 $33.6 Million
Q2 2021 Aug 13, 2021	BUY	$19.57 - $26.32 $49 Million - $65.9 Million	2,502,826 New	2,502,826 $54.9 Million

Others Institutions Holding GTHX

# of Institutions

Shares Held

18.2M

Call Options Held

1.85M

Put Options Held

1.18M

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc G1 Therapeutics, Inc. Transaction History